{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T07:57:34Z","timestamp":1719043054489},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1471-2377-14-139","type":"journal-article","created":{"date-parts":[[2014,7,2]],"date-time":"2014-07-02T04:28:37Z","timestamp":1404275317000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["An immunoassay that distinguishes real neuromyelitis optica signals from a labeling detected in patients receiving natalizumab"],"prefix":"10.1186","volume":"14","author":[{"given":"Ismael","family":"S\u00e1nchez Gomar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"D\u00edaz S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio Jos\u00e9","family":"Ucl\u00e9s S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Luis","family":"Casado Choc\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reposo","family":"Ram\u00edrez-Lorca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Serna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Villadiego","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Jos\u00e9","family":"Toledo-Aral","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam","family":"Echevarr\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,7,1]]},"reference":[{"key":"1060_CR1","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/S1474-4422(07)70216-8","volume":"6","author":"DM Wingerchuk","year":"2007","unstructured":"Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BG: The spectrum of neuromyelitis optica. Lancet Neurol. 2007, 6: 805-815.","journal-title":"Lancet Neurol"},{"key":"1060_CR2","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","volume":"66","author":"DM Wingerchuk","year":"2006","unstructured":"Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG: Revised diagnostic criteria for neuromyelitis optica. Neurology. 2006, 66: 1485-1489.","journal-title":"Neurology"},{"key":"1060_CR3","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","volume":"364","author":"VA Lennon","year":"2004","unstructured":"Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K, Nakashima I, Weinshenker BG: A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet. 2004, 364: 2106-2112.","journal-title":"Lancet"},{"key":"1060_CR4","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1212\/01.wnl.0000256822.01222.bd","volume":"68","author":"S Jarius","year":"2007","unstructured":"Jarius S, Franciotta D, Bergamaschi R, Wright H, Littleton E, Palace J, Hohlfeld R, Vincent A: NMO-IgG in the diagnosis of neuromyelitis optica. Neurology. 2007, 68: 1076-1077.","journal-title":"Neurology"},{"key":"1060_CR5","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1001\/archneur.63.7.964","volume":"63","author":"SJ Pittock","year":"2006","unstructured":"Pittock SJ, Weinshenker BG, Lucchinetti CF, Wingerchuk DM, Corboy JR, Lennon VA: Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression. Arch Neurol. 2006, 63: 964-968.","journal-title":"Arch Neurol"},{"key":"1060_CR6","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.neuroscience.2010.04.071","volume":"168","author":"M Amiry-Moghaddam","year":"2010","unstructured":"Amiry-Moghaddam M, Hoddevik EH, Ottersen OP: Aquaporins: multifarious roles in brain. Neuroscience. 2010, 168: 859-861.","journal-title":"Neuroscience"},{"key":"1060_CR7","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.neuint.2010.03.022","volume":"57","author":"M Zelenina","year":"2010","unstructured":"Zelenina M: Regulation of brain aquaporins. Neurochem Int. 2010, 57: 468-488.","journal-title":"Neurochem Int"},{"key":"1060_CR8","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S0306-4522(99)00182-7","volume":"94","author":"JL Venero","year":"1999","unstructured":"Venero JL, Vizuete ML, Ilundain AA, Machado A, Echevarria M, Cano J: Detailed localization of aquaporin-4 messenger RNA in the CNS: preferential expression in periventricular organs. Neuroscience. 1999, 94: 239-250.","journal-title":"Neuroscience"},{"key":"1060_CR9","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1191\/1352458505ms1236cr","volume":"11","author":"M Nakamura","year":"2005","unstructured":"Nakamura M, Endo M, Murakami K, Konno H, Fujihara K, Itoyama Y: An autopsied case of neuromyelitis optica with a large cavitary cerebral lesion. Mult Scler. 2005, 11: 735-738.","journal-title":"Mult Scler"},{"key":"1060_CR10","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1111\/j.1749-6632.2009.04871.x","volume":"1173","author":"R Cayrol","year":"2009","unstructured":"Cayrol R, Saikali P, Vincent T: Effector functions of antiaquaporin-4 autoantibodies in neuromyelitis optica. Ann N Y Acad Sci. 2009, 1173: 478-486.","journal-title":"Ann N Y Acad Sci"},{"key":"1060_CR11","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.jns.2011.02.018","volume":"306","author":"K Fujihara","year":"2011","unstructured":"Fujihara K: Neuromyelitis optica and astrocytic damage in its pathogenesis. J Neurol Sci. 2011, 306: 183-187.","journal-title":"J Neurol Sci"},{"key":"1060_CR12","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1093\/brain\/awf151","volume":"125","author":"CF Lucchinetti","year":"2002","unstructured":"Lucchinetti CF, Mandler RN, McGavern D, Bruck W, Gleich G, Ransohoff RM, Trebst C, Weinshenker B, Wingerchuk D, Parisi JE, Lassmann H: A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain. 2002, 125: 1450-1461.","journal-title":"Brain"},{"key":"1060_CR13","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1093\/brain\/awl371","volume":"130","author":"SF Roemer","year":"2007","unstructured":"Roemer SF, Parisi JE, Lennon VA, Benarroch EE, Lassmann H, Bruck W, Mandler RN, Weinshenker BG, Pittock SJ, Wingerchuk DM, Lucchinetti CF: Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. Brain. 2007, 130: 1194-1205.","journal-title":"Brain"},{"key":"1060_CR14","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/j.neuroscience.2009.08.032","volume":"168","author":"SR Hinson","year":"2010","unstructured":"Hinson SR, McKeon A, Lennon VA: Neurological autoimmunity targeting aquaporin-4. Neuroscience. 2010, 168: 1009-1018.","journal-title":"Neuroscience"},{"key":"1060_CR15","first-page":"72","volume":"33","author":"NJ Santiesteban","year":"2009","unstructured":"Santiesteban NJ, Marrero M, Gonz\u00e1lez TM, Armenteros VK: Neuromielitis \u00f3ptica. Neurociruj\u00eda. 2009, 33: 72-77.","journal-title":"Neurociruj\u00eda"},{"key":"1060_CR16","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1007\/s00415-007-0509-8","volume":"254","author":"A Saiz","year":"2007","unstructured":"Saiz A, Zuliani L, Blanco Y, Tavolato B, Giometto B, Graus F: Revised diagnostic criteria for neuromyelitis optica (NMO). J Neurol. 2007, 254: 1233-1237.","journal-title":"J Neurol"},{"key":"1060_CR17","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1177\/1352458509106851","volume":"15","author":"R Fazio","year":"2009","unstructured":"Fazio R, Malosio ML, Lampasona V, De Feo D, Privitera D, Marnetto F, Centonze D, Ghezzi A, Comi G, Furlan R, Martino G: Antiacquaporin 4 antibodies detection by different techniques in neuromyelitis optica patients. Mult Scler. 2009, 15: 1153-1163.","journal-title":"Mult Scler"},{"key":"1060_CR18","first-page":"1134","volume":"66","author":"A McKeon","year":"2009","unstructured":"McKeon A, Fryer JP, Apiwattanakul M: Diagnosis of neuromyelitis spectrum disorders: Comparative sensitivities and specificities of immunohistochemical and immunoprecipitation assays. Arch Neurol. 2009, 66: 1134-1138.","journal-title":"Arch Neurol"},{"key":"1060_CR19","first-page":"99","volume":"15","author":"P Waters","year":"2008","unstructured":"Waters P, Vincent A: Detection of anti-aquaporin-4 antibodies in neuromyelitis optica: current status of the assays. Int MS J. 2008, 15: 99-105.","journal-title":"Int MS J"},{"key":"1060_CR20","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/ncpneuro0764","volume":"4","author":"S Jarius","year":"2008","unstructured":"Jarius S, Paul F, Franciotta D, Waters P, Zipp F, Hohlfeld R, Vincent A, Wildemann B: Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica. Nat Clin Pract Neurol. 2008, 4: 202-214.","journal-title":"Nat Clin Pract Neurol"},{"key":"1060_CR21","doi-asserted-by":"publisher","first-page":"e133","DOI":"10.1371\/journal.pmed.0040133","volume":"4","author":"F Paul","year":"2007","unstructured":"Paul F, Jarius S, Aktas O, Bluthner M, Bauer O, Appelhans H, Franciotta D, Bergamaschi R, Littleton E, Palace J, Seelig HP, Hohlfeld R, Vincent A, Zipp F: Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica. PLoS Med. 2007, 4: e133-","journal-title":"PLoS Med"},{"key":"1060_CR22","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1001\/archneur.65.7.913","volume":"65","author":"P Waters","year":"2008","unstructured":"Waters P, Jarius S, Littleton E: Aquaporin-4 antibodies in neuromyelitis optica and longitudinally extensive transverse myelitis. Arch Neurol. 2008, 65: 913-919.","journal-title":"Arch Neurol"},{"key":"1060_CR23","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jneuroim.2008.03.009","volume":"196","author":"S Hayakawa","year":"2008","unstructured":"Hayakawa S, Mori M, Okuta A, Kamegawa A, Fujiyoshi Y, Yoshiyama Y, Mitsuoka K, Ishibashi K, Sasaki S, Hattori T, Kuwabara S: Neuromyelitis optica and anti-aquaporin-4 antibodies measured by an enzyme-linked immunosorbent assay. J Neuroimmunol. 2008, 196: 181-187.","journal-title":"J Neuroimmunol"},{"key":"1060_CR24","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.jns.2012.06.002","volume":"320","author":"S Jarius","year":"2012","unstructured":"Jarius S, Franciotta D, Paul F, Bergamaschi R, Rommer PS, Ruprecht K, Ringelstein M, Aktas O, Kristoferitsch W, Wildemann B: Testing for antibodies to human aquaporin-4 by ELISA: Sensitivity, specificity, and direct comparison with immunohistochemistry. J Neurol Sci. 2012, 320: 32-37.","journal-title":"J Neurol Sci"},{"key":"1060_CR25","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1620\/tjem.210.307","volume":"210","author":"T Takahashi","year":"2006","unstructured":"Takahashi T, Fujihara K, Nakashima I, Misu T, Miyazawa I, Nakamura M, Watanabe S, Ishii N, Itoyama Y: Establishment of a new sensitive assay for anti-human aquaporin-4 antibody in neuromyelitis optica. Tohoku J Exp Med. 2006, 210: 307-313.","journal-title":"Tohoku J Exp Med"},{"key":"1060_CR26","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/ana.22366","volume":"69","author":"CH Polman","year":"2011","unstructured":"Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, Fujihara K, Havrdova E, Hutchinson M, Kappos L, Lublin FD, Montalban X, O'Connor P, Sandberg-Wollheim M, Thompson AJ, Waubant E, Weinshenker B, Wolinsky JS: Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria. Ann Neurol. 2011, 69: 292-302.","journal-title":"Ann Neurol"},{"key":"1060_CR27","doi-asserted-by":"publisher","first-page":"e28385","DOI":"10.1371\/journal.pone.0028385","volume":"6","author":"I Abreu-Rodr\u00edguez","year":"2011","unstructured":"Abreu-Rodr\u00edguez I, S\u00e1nchez Silva R, Martins AP, Soveral G, Toledo-Aral JJ, L\u00f3pez-Barneo J, Echevarr\u00eda M: Functional and transcriptional induction of aquaporin-1 gene by hypoxia; analysis of promoter and role of Hif-1alpha. PLoS One. 2011, 6: e28385-","journal-title":"PLoS One"},{"key":"1060_CR28","doi-asserted-by":"publisher","first-page":"16516","DOI":"10.1074\/jbc.M111.227298","volume":"286","author":"JM Crane","year":"2011","unstructured":"Crane JM, Lam C, Rossi A, Gupta T, Bennett JL, Verkman AS: Binding affinity and specificity of neuromyelitis optica autoantibodies to aquaporin-4\u00a0M1\/M23 isoforms and orthogonal arrays. J Biol Chem. 2011, 286: 16516-16524.","journal-title":"J Biol Chem"},{"key":"1060_CR29","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1002\/glia.20855","volume":"57","author":"GP Nicchia","year":"2009","unstructured":"Nicchia GP, Mastrototaro M, Rossi A, Pisani F, Tortorella C, Ruggieri M, Lia A, Trojano M, Frigeri A, Svelto M: Aquaporin-4 orthogonal arrays of particles are the target for neuromyelitis optica autoantibodies. Glia. 2009, 57: 1363-1373.","journal-title":"Glia"},{"key":"1060_CR30","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1177\/1352458512460604","volume":"19","author":"A Vennegoor","year":"2013","unstructured":"Vennegoor A, Rispens T, Strijbis EM, Seewann A, Uitdehaag BM, Balk LJ, Barkhof F, Polman CH, Wolbink G, Killestein J: Clinical relevance of serum natalizumab concentration and anti-natalizumab antibodies in multiple sclerosis. Mult Scler. 2013, 19: 593-600.","journal-title":"Mult Scler"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2377-14-139.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2377-14-139\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2377-14-139","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2377-14-139.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T08:25:31Z","timestamp":1630571131000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/1471-2377-14-139"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["1060"],"URL":"https:\/\/doi.org\/10.1186\/1471-2377-14-139","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,1]]},"assertion":[{"value":"27 January 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"139"}}